Europe Lactoferrin Market was worth USD 15.36 million in 2018, and is expected to grow at a CAGR of 8.9%, to reach USD 23.53 million by 2023. Lactoferrin is a globular glycoprotein of the transferrin family. It is commonly present in several fluid secretions of humans such as milk, tears, saliva and nasal secretions. Human colostrum, first milk produced from mammary glands after child birth has highest concentration of lactoferrin. Human milk and cow milk follows colostrum respectively in terms of concentration.
Lactoferrin can be extracted or separated from milk or by using recombinant DNA modification techniques. Lactoferrin is involved in several biological activities such as antimicrobial activity especially in children, stimulation of immune cells and iron absorption. It also aids in bone formation and increase in anti-inflammatory responses of the body. Infants benefit highly from lactoferrin.
The numerous health benefits offered by lactoferrin protein in adults as well as infants have increased the demand for lactoferrin products. Factors such as rising prevalence of bacterial and viral infections, its prominent role in immune responses such as anti-inflammation and its ability to absorb iron are expected to drive the market. Advanced techniques to extract lactoferrin from skimmed milk resulting in increased production are also expected to propel the market. However, lack of awareness among people and high cost of products are inhibiting the market growth.
The Lactoferrin Market is categorized based on the function, application, and region. Based on the function, the market is categorized into Anti-inflammatory, Iron Absorption, Antibacterial, Intestinal Flora Protection, Antioxidant, Immune Cell Stimulation and others. The iron absorption property of lactoferrin is very important and is very helpful in initial growth of infants and hence this segment holds the largest market. Based on application, the market is categorized into Food and Beverages, Infant Formula, Sports and Functional Foods, Animal Feed, Pharmaceuticals and Personal care Products. Infant formula contributes the largest market share. It is due to the excessive use of lactoferrin in infant formula due to its antibacterial, iron absorbing and bone forming properties.
Based on region, the Europe market is categorized into U.K, Germany, France, Italy and Spain. Europe is expected to be the fastest growing market segment due to the favorable regulations by European Union regarding the use of lactoferrin in several products.
Some of the major players in this region are Glanbia Nutritionals, Westland Co-Operative Dairy Co. Ltd. Fonterra Co-Operative Group Ltd., MP Biomedicals, Synlait Milk Ltd., Ingredia SA, Vitalus Nutrition Inc., ProHealth and Metagenics.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Function
5.1.1 Introduction
5.1.2 Anti-inflammatory
5.1.3 Iron Absorption
5.1.4 Antibacterial
5.1.5 Intestinal Flora Protection
5.1.6 Antioxidant
5.1.7 Immune Cell Stimulation
5.1.8 Others
5.1.9 Y-o-Y Growth Analysis, By Function
5.1.10 Market Attractiveness Analysis, By Function
5.1.11 Market Share Analysis, By Function
5.2 Application
5.2.1 Introduction
5.2.2 Food and Beverages
5.2.3 Infant Formula
5.2.4 Sports and Functional Foods
5.2.5 Animal Feed
5.2.6 Pharmaceuticals
5.2.7 Personal care Products
5.2.8 Others
5.2.9 Y-o-Y Growth Analysis, By Application
5.2.10 Market Attractiveness Analysis, By Application
5.2.11 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Function
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Function
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Function
6.1.5.3 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Glanbia Nutritionals
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Westland Co-Operative Dairy Co. Ltd
8.3 Fonterra Co-Operative Group Ltd
8.4 MP Biomedicals
8.5 Synlait Milk Ltd.
8.6 Ingredia SA
8.7 Vitalus Nutrition Inc
8.8 ProHealth
8.9 Metagenics
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
